CYP19A1 and breast carcinoma: Indeed, our group has demonstrated that THC and CBD decrease aromatase and ERα protein levels in ER+ breast cancer cells and that CBD can also inhibit aromatase [42] and presents ER and AR antagonistic, as well as inverse agonist, properties, in both receptors [44].